<!DOCTYPE html>
<html lang="cnr" class="no-js">
    <head>
        <meta charset="utf-8">
        <script src="https://cdnjs.cloudflare.com/ajax/libs/modernizr/2.8.3/modernizr.min.js"></script>
        <script crossorigin="anonymous" src="https://polyfill.io/v3/polyfill.min.js?features=Promise%2CArray.prototype.forEach%2CString.prototype.includes%2CURLSearchParams%2CCustomEvent%2CArray.prototype.includes%2CArray.prototype.filter%2CArray.prototype.some%2CArray.prototype.find%2CArray.prototype.reduce%2CObject.assign%2CArray.isArray%2CObject.values%2CObject.entries%2CArray.from%2CSet%2CArray.prototype.findIndex"></script>
<script crossorigin="anonymous" src="https://cdnjs.cloudflare.com/ajax/libs/javascript-canvas-to-blob/3.15.0/js/canvas-to-blob.min.js"></script>

        <script>
// This is where we initialise any global variables, namespaced in "opensdg".
var opensdg = {

  // A base URL for asynchronous calls to SDG data.
  remoteDataBaseUrl: 'https://montestat.github.io/data/cnr',

  chartConfigAlterations: [],
  // A hook which can be used to modify the configuration for Chart.js.
  chartConfigAlter: function(callback) {
    this.chartConfigAlterations.push(callback);
  },

  tableConfigAlterations: [],
  // A hook which can be used to modify the configuration for Datatables.
  tableConfigAlter: function(callback) {
    this.tableConfigAlterations.push(callback);
  },

  // A hook which can be replaced to alter whether/how the values that are
  // displayed on indicator tables/graphs get rounded.
  dataRounding: function(value) {
    // Alterations go here.
    return value;
  },

  // A hook which can be used to alter the data before it is displayed on charts/tables.
  dataDisplayAlterations: [],
  dataDisplayAlter: function(callback) {
    this.dataDisplayAlterations.push(callback);
  },

  language: 'cnr',
};

</script>

        <script>
// JavaScript container for translation data.
var translations = {
  //Javascript version of the "t" filter from jekyll-open-sdg-plugins.
  t: function(key) {

    if (!key || typeof key !== 'string') {
      return '';
    }

    // The majority of uses of this function are to translate disaggregation
    // data. To spare data providers of needing to enter "data." in front of
    // their disaggregation data, we specifically look for that here.
    if (typeof this.data === 'object' && this.data !== null && this.data[key]) {
      return this.data[key];
    }

    var originalKey = key;
    var drilled = this;
    var levelsDrilled = 0;
    var levels = key.split('.');

    for (var level in levels) {
      // If we have drilled down to soon, abort.
      if (typeof drilled !== 'object') {
        break;
      }

      if (levels[level] in drilled) {
        drilled = drilled[levels[level]];
        levelsDrilled += 1;
      }
    }

    // If we didn't drill the right number of levels, return the original string.
    if (levels.length != levelsDrilled) {
      return originalKey;
    }

    // Otherwise we must have drilled all the way.
    return drilled;
  },
};
</script>

        <!-- Basic Page Needs
        ================================================== -->
        <meta http-equiv="X-UA-Compatible" content="IE=edge"><!-- Mobile Specific Metas
        ================================================== -->
        <meta name="HandheldFriendly" content="True">
        <meta name="MobileOptimized" content="320">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">
        <!-- Title and meta description
        ================================================== -->

        
    <title>
        
        Indikator 3.b.3 -
        
        Udio zdravstvenih ustanova koje imaju osnovni set relevantnih esencijalnih ljekova dostupnih i pristupačnih na održivoj osnovi - Indikatori za Ciljeve održivog razvoja
    </title>



        <meta name="description" content="">
        <meta property="og:description" content="">
        
        <meta name="robots" content="noindex, nofollow">
        
        <link rel="canonical" href="/">

        <!--[if IE 9]>
        <script src="/site/assets/js/lib/classList.js"></script>
        <![endif]-->

        <link rel="apple-touch-icon" sizes="180x180" href="/site/assets/img/favicons/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/site/assets/img/favicons/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/site/assets/img/favicons/favicon-16x16.png">
<link rel="icon" type="image/x-icon" href="/site/assets/img/favicons/favicon.ico" />


        
        <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.2/dist/css/bootstrap.min.css" rel="stylesheet" integrity="sha384-EVSTQN3/azprG1Anm3QDgpJLIm9Nao0Yz1ztcQTwFspd3yD65VohhpuuCOmLASjC" crossorigin="anonymous">
        <link res="stylesheet" href="https://cdn.datatables.net/1.11.5/css/dataTables.bootstrap5.min.css">
        <link rel="stylesheet" href="//maxcdn.bootstrapcdn.com/font-awesome/4.5.0/css/font-awesome.min.css" crossorigin="">
        <link rel="stylesheet" href="https://cdn.datatables.net/fixedcolumns/3.2.3/css/fixedColumns.dataTables.min.css" crossorigin="">
        <link rel="stylesheet" href="/site/assets/css/style.css?v=20220721145210">
        <link rel="stylesheet" href="https://unpkg.com/leaflet@1.3.4/dist/leaflet.css"
          integrity="sha512-puBpdR0798OZvTTbP4A8Ix/l+A4dHDD0DGqYW6RQ+9jxkRFclaxxQb/SJAWZfWAkuyeQUytO7+7N4QKrDh+drA=="
          crossorigin=""/>
        <link rel="stylesheet" href="https://cdn.rawgit.com/socib/Leaflet.TimeDimension/master/dist/leaflet.timedimension.control.min.css"  crossorigin=""/>
        <link rel="stylesheet" href='https://api.mapbox.com/mapbox.js/plugins/leaflet-fullscreen/v1.0.1/leaflet.fullscreen.css'  crossorigin=""/>
        <link rel="stylesheet" href="https://bowercdn.net/c/leaflet.zoomhome-latest/dist/leaflet.zoomhome.css"  crossorigin=""/>
        <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/leaflet-search@2.9.7/dist/leaflet-search.min.css" crossorigin="">
        <link rel="stylesheet" href="https://cdn.kiprotect.com/klaro/v0.7/klaro.min.css" crossorigin=""/>
        

        <!--[if IE]>
        <link rel="stylesheet" href="/site/assets/css/ie.css">
        <![endif]-->

        

    </head>
<body class="language-cnr
layout-indicator
">
<!-- <div class="container"> -->

<script>translations['header'] = {"alpha":"Alfa","default_contrast":"Podrazumijevani kontrast","disable_high_contrast":"Onemogućite visoki kontrast","disclaimer":"Ovo je razvojna web stranica. Dobrodošle su vaše <a href=\"mailto:%email_contacts.suggestions\">povratne informacije</a>.","enable_high_contrast":"Omogućite visoki kontrast","high_contrast":"Visoki kontrast","internet_explorer_message":"Otkrili smo da koristite Internet Ekplorer da biste posjetili ovu web stranicu. Microsoft sada ukida Internet Ekplorer. Kao rezultat toga, ova web lokacija više ne podržava nijednu verziju Internet Ekplorer-a. Neke funkcije na ovom sajtu neće raditi. Trebalo bi da koristite moderan pretraživač kao što je Edge, Chrome, Firefox ili Safari. Ako imate poteškoća sa instaliranjem ili pristupom drugom pretraživaču, kontaktirajte svoj tim za IT podršku.","internet_explorer_message_title":"Ovaj internet pretraživač više nije podržan","skip_link":"Preskoči na glavni sadržaj","tag_line":"17 ciljeva za transformaciju našeg svijeta","toggle_menu":"Podešavanje menija. Kliknite da biste proširili ili skupili meni.","toggle_search":"Podešavanje pretrage. Kliknite da proširite ili suzite traku za pretraživanje."};</script>

<a class="sr-only-focusable" id="skiplink" href="#main-content" tabindex="0">Preskoči na glavni sadržaj</a>
<div class="container internet-explorer-message">
    <h2 class="internet-explorer-message-title">Ovaj internet pretraživač više nije podržan</h2>
    <p class="internet-explorer-message-body">Otkrili smo da koristite Internet Ekplorer da biste posjetili ovu web stranicu. Microsoft sada ukida Internet Ekplorer. Kao rezultat toga, ova web lokacija više ne podržava nijednu verziju Internet Ekplorer-a. Neke funkcije na ovom sajtu neće raditi. Trebalo bi da koristite moderan pretraživač kao što je Edge, Chrome, Firefox ili Safari. Ako imate poteškoća sa instaliranjem ili pristupom drugom pretraživaču, kontaktirajte svoj tim za IT podršku.</p>
</div>
<div id="disclaimer">
    
<div class="container">
  <div class="disclaimer-alert">
    <strong class="phase-tag">Alfa</strong>
    
    Ovo je razvojna web stranica. Dobrodošle su vaše <a href="mailto:montenegrosdg@gmail.com">povratne informacije</a>.
    
  </div>
</div>

</div>

<header role="banner" class="">
    <div class="container">
        <nav class="navbar navbar-expand-lg navbar-light flex-wrap align-items-start">
            <a class="navbar-brand" href="/site/" id="home">
    <img src="/site/assets/img/logo/cnr/SDG_logo.png" alt="Crna Gora" />
</a>
            <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarSupportedContent" aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation">
                <span class="navbar-toggler-icon"></span>
            </button>
            <div class="d-flex flex-wrap w-100 justify-content-between">
                <div class="collapse navbar-collapse" id="navbarSupportedContent">
                    <ul class="navbar-nav" id="menu"><li class="nav-item ">
    <a class="nav-link" href="/site/goals">Ciljevi</a>
</li><li class="nav-item ">
    <a class="nav-link" href="/site/reporting-status">Status izvještavanja</a>
</li><li class="nav-item ">
    <a class="nav-link" href="/site/about">O nama</a>
</li><li class="nav-item ">
    <a class="nav-link" href="/site/news">Novosti</a>
</li></ul>
    
                </div>
                <div class="header-search-bar">
                    <form class="align-self-lg-end" id="search" action="/site/search/">
    <div class="input-group">
        <label class="visually-hidden" for="indicator_search">Pretraga</label>
        <input class="form-control" type="search" name="q" id="indicator_search" title="Pretraga">
        <span class="input-group-append">
            <button class="btn btn-outline-secondary ms-n5" aria-label="Pretraga" id="search-btn" type="submit">
                <i class="fa fa-search"></i>
            </button>
        </span>
    </div>
</form>

                </div>
                <div class="header-toggles d-flex">





  <div class="language-toggle-container">
  
  <div class="btn-group language-toggle-dropdown  dropdown">
    <button class="btn dropdown-toggle" type="button" data-bs-toggle="dropdown" aria-expanded="false">
      <i class="fa fa-globe"></i>
      Crnogorski
    </button>
    <ul class="dropdown-menu"><li>
            <a class="dropdown-item" href="/site/en/3-b-3/">
              Engleski
            </a>
          </li></ul>
  </div>
</div>



                    <span class="no-js-language-toggle"><div class="language-toggle-container d-flex">
    <i class="fa fa-globe language-toggle-globe-links"></i>
    <ul class="language-toggle-links list-unstyled list-inline"><li class="language-option-en list-inline-item">
            <a class="language-toggle-link" href="/site/en/3-b-3/">
                Engleski
            </a>
        </li></ul>
</div></span><a title="Omogućite visoki kontrast" aria-label="Omogućite visoki kontrast"
    data-contrast-switch-to="" href="javascript:void(0)" data-on="click"
data-event-category="Accessibility"
data-event-action="Change contrast setting"
data-event-label="high"
>A</a>
                </div>
            </div>
        </nav>
    </div>
</header>
<div id="top" tabindex=-1></div>



<script type="text/template" id="item_template">
  <% _.each(fields, function(fieldItem) { %>
    <div class="variable-selector
      <% if(allowedFields.indexOf(fieldItem.field) == -1) { %> disallowed <% }%>
      <% if (typeof childFields !== 'undefined' && childFields.indexOf(fieldItem.field) !== -1) { %> child <% }%>
      "
      data-field="<%=fieldItem.field%>"
    >
      <button class='accessBtn' tabindex='0' aria-expanded='false'
        <% if(allowedFields.indexOf(fieldItem.field) == -1) { %>
        aria-describedby='variable-hint-<%=fieldItem.field.replace(/ /g, '-')%>'
        <% }%>
      >
        <% if(allowedFields.indexOf(fieldItem.field) == -1) { %><h6><% } else { %><h5><% } %>
          <span aria-hidden="true"><%=translations.t(fieldItem.label)%><i class="fa fa-chevron-down"></i></span>
          <span class="sr-only">Prikaži potkategorije: <%=translations.t(fieldItem.label)%></span>
        <% if(allowedFields.indexOf(fieldItem.field) == -1) { %></h6><% } else { %></h5><% } %>
      </button>
      <div class="variable-options">
        <fieldset>
          <legend class="sr-only">Potkategorije - <%=translations.t(fieldItem.field)%></legend>
          <div>
            <button data-type="select">Označi sve</button>
            <button data-type="clear">Obriši sve</button>
          </div>
          <% _.each(fieldItem.values, function(item) { %>
            <label>
              <input type="checkbox" <%=item.checked ? 'checked' : ''%> value="<%=item.value%>" data-field="<%=fieldItem.field%>" /><%=translations.t(item.value)%>
            </label>
          <% }); %>
        </fieldset>
      </div>

      <% if(allowedFields.indexOf(fieldItem.field) == -1) { %>
        <div class="variable-hint" id="variable-hint-<%=fieldItem.field.replace(/ /g, '-')%>">Dostupno kada je odabrano '<%= translations.t(_.find(edges, { To: fieldItem.field }).From) %>'
        </div>
        <div class="no-data-hint" id="no-data-hint-<%=fieldItem.field.replace(/ /g, '-')%>">
          Nema dostupnih opcija zbog gornjih filtera
        </div>
      <% }%>

    </div>
  <% }); %>
</script>

<script type="text/template" id="units_template">
  
  <% if(units.length > 1) { %>
  
    <h4>Jedinica mjere</h4>
    <fieldset>
      <legend class="sr-only">Jedinica mjere</legend>
      <% _.each(units, function(unitsItem, index) { %>
        <% var checked = (selectedUnit) ? (selectedUnit==unitsItem) : (index==0); %>
        <label><input type="radio" name="unit" value="<%=unitsItem%>" tabindex=0 <%=checked ? 'checked' : ''%> /> <%=translations.t(unitsItem)%></label>
      <% }); %>
    </fieldset>
  
  <% } %>
  
</script>

<script type="text/template" id="series_template">
  
  <% if(serieses.length > 1) { %>
  
    <h4>Niz</h4>
    <fieldset>
      <legend class="sr-only">Niz</legend>
      <% _.each(serieses, function(seriesItem, index) { %>
        <% var checked = (selectedSeries) ? (selectedSeries==seriesItem) : (index==0); %>
        <label><input type="radio" name="series" value="<%=seriesItem%>" tabindex=0 <%=checked ? 'checked' : ''%> /> <%=translations.t(seriesItem)%></label>
      <% }); %>
    </fieldset>
  
  <% } %>
  
</script>

<script>translations['indicator'] = {"annotation_2030_target":"Cilj indikatora 2030","annotation_series_break":"Prekid niza","announce_data_added":"Grafik i tabela su ažurirani kako bi uključili podatke.","announce_data_not_available":"Na grafiku i tabeli nema podataka.","announce_data_removed":"Grafik i tabela su ažurirani kako bi se isključili podaci.","apply":"Primijeniti","cancel":"Poništiti","change_breakdowns":"Promjena kvarova","chart":"Grafik","chart_annotation":"Označavanje grafika","clear_all":"Obriši sve","clear_selections":"Obrišite odabire","data_keyboard_navigation":"Pritisnite enter da biste pretraživali podatke pomoću tipki sa strelicama lijevo i desno.","data_not_available":"Ovi podaci nijesu dostupni. Molimo odaberite alternativne podatke za prikaz.","data_tabular_alternative":"Kao alternativu tabelarnih podataka pogledajte Tabelu.","dataset_size_warning":"Previše je skupova podataka za prikaz na grafiku. Neće se sve prikazati dok ne uklonite neke odabire.","download_chart":"Preuzmite CSV grafik","download_chart_image":"Preuzmite sliku grafika","download_chart_image_title":"Preuzmite grafik kao sliku","download_csv":"Preuzmite CSV","download_csv_title":"Preuzmite kao CSV","download_geojson":"Preuzmite GeoJSON","download_geojson_title":"Preuzmite kao GeoJSON","download_headline":"Preuzmite naslovni CSV","download_headline_title":"Preuzmite podatke naslova kao CSV","download_source":"Preuzmite izvorni CSV","download_source_for_disaggregations":"Preuzmite izvorni CSV za disagregacije","download_source_sdmx":"Preuzmite izvorni SDMX","download_source_sdmx_title":"Preuzmite izvorne podatke kao SDMX","download_source_title":"Preuzmite izvorne podatke kao CSV","download_table":"Preuzmite CSV tabelu","edit":"Urediti","edit_configuration":"Urediti konfiguraciju","edit_data":"Urediti podatke","edit_metadata":"Urediti metapodatke","footnote":"Fusnota","geographical_area":"Geografsko područje","global_metadata":"Globalni metapodaci","global_metadata_blurb":"Ova tabela pruža informacije o metapodacima za COR indikatore koje je definisala Statistička komisija UN-a. <a href=\"https://unstats.un.org/sdgs/metadata/\">Kompletne globalne metapodatke</a> obezbjeđuje Odjeljenje za statistiku UN-a.","headline_data":"Naslovni podaci","legend_help":"Kliknite na legendu da uklonite pojedinačne linije sa grafika.","loading":"Učitavanje","loading_map":"Učitavanje mape","map":"Mapa","map_search":"Pretraga","map_search_hide":"Sakrij pretragu","map_search_show":"Prikaži pretragu","map_year_slider":"Klizač za godinu","national_metadata":"Nacionalni metapodaci","national_metadata_blurb":"Ova tabela pruža više informacija o indikatoru koji je dostupan iz crnogorske statistike a najbliže odgovara globalnom indikatoru COR. Imajte na umu da i kada je globalni indikator COR u potpunosti dostupan iz crnogorske statistike, ovu tabelu treba konsultovati za informacije o nacionalnoj metodologiji i druge informacije o crnogorskim metapodacima.","next":"Sljedeći indikator","no_data_hint":"Nema dostupnih opcija zbog gornjih filtera","no_headline_data":"Nema dostupnih naslovnih podataka","plot_legend_description":"Legenda grafika: lista linija uključenih u grafik","previous":"Prethodni indikator","select_all":"Označi sve","series":"Niz","series_help":"Odaberite kategorije iz padajućih menija u nastavku da vidite različite tipove podataka. Neki podaci neće biti dostupni dok se ne odabere viši nivo pretrage.","source":"Izvor","sources":"Izvori","status":"Status indikatora","sub_categories":"Potkategorije","sub_categories_show":"Prikaži potkategorije:","table":"Tabela","table_column_sort":"Kliknite da biste sortirali po ovoj koloni","tags":"Oznake","unit":"Jedinica","unit_of_measurement":"Jedinica mjere","units_type":"Tip jedinica","variable_hint":"Dostupno kada je odabrano '%field'","view_indicator_list":"Pogledajte listu indikatora ovog cilja"};</script>

<script>translations['data'] = {"Age":"Starost","Female":"Žene","Male":"Muškarci","Sex":"Pol","Units":"Jedinica","Value":"Vrijednost","Year":"Godina","aged 0-17 years":"Manje od 18 godina","aged 18-24 years":"18-24 godine","aged 18-64 years":"18-64 godine","aged 25-54 years":"25-54 godine","aged 55-64 years":"55-64 godine","aged over 65 years":"65 ili više godina"};</script>


<div class="container">
  
<nav>
    <ol aria-label="breadcrumb" class="breadcrumb" style="--bs-breadcrumb-divider: '&rsaquo;';">
        
        <li class="breadcrumb-item">
            <a href="/site/">Naslovna</a>
        </li>
        <li class="breadcrumb-item">
            <a href="/site/goals">Ciljevi</a>
        </li>
        
        <li class="breadcrumb-item">
            <a href="/site/3" title="Obezbijediti zdrave živote i promovisati dobrobit za sve ljude u svim uzrastima">Cilj 3</a>
        </li>
        
    </ol>
</nav>


  
</div>
<div class="heading goal-banner indicator goal-3">
    <div class="container">
        <div class="row">
            
            <div class="col-4 col-md-3 col-lg-2 goal-icon goal-tiles">
                <a href="/site/3" title="Pogledajte listu indikatora ovog cilja">
                    <img src="https://montestat.github.io/site/assets/img/goals/cnr/3.png"
                        alt="Dobro zdravlje i blagostanje - Cilj 3"
                        id="goal-3"
                        class="goal-icon-image goal-icon-image-" />
                </a>
            </div>
            <div class="col-8 col-md-9 col-lg-10 indicator-details">
            
                <div>
                    <h1>
                        
                        Indikator 3.b.3
                        
                        <span class="lead-copy">Udio zdravstvenih ustanova koje imaju osnovni set relevantnih esencijalnih ljekova dostupnih i pristupačnih na održivoj osnovi</span>
                    </h1>
                </div>
            </div>
        </div>
    </div>
</div>
<div id="main-content" class="container goal-3" role="main">
  

  

  

  


  



<div class="row"
  id="indicatorData"
  data-indicatorid='indicator_3-b-3'
  data-id="3-b-3"
  data-country="custom.country_name"
  data-charttitle="Udio zdravstvenih ustanova koje imaju osnovni set relevantnih esencijalnih ljekova dostupnih i pristupačnih na održivoj osnovi"
  data-charttitles="[]"
  data-measurementunit=""
  data-xaxislabel=""
  data-showdata="false"
  data-graphtype="line"
  data-graphtypes="null"
  data-geocoderegex=""
  data-showmap="false"
  data-startvalues="[]"
  data-graphlimits="[]"
  data-stackeddisaggregation=""
  data-graphannotations="[]"
  data-graphtargetlines="null"
  data-graphseriesbreaks="null"
  data-indicatordownloads="null"
  data-dataschema="{&quot;fields&quot;:[{&quot;name&quot;:&quot;Year&quot;,&quot;type&quot;:&quot;number&quot;,&quot;title&quot;:&quot;Godina&quot;},{&quot;name&quot;:&quot;Value&quot;,&quot;type&quot;:&quot;number&quot;,&quot;title&quot;:&quot;Vrijednost&quot;}]}"
  data-compositebreakdownlabel=""
  data-precision="[]"
>
  
  <div id="indicator-main" class="indicator-main col-md-12">
  
  <div class="mt-4">
<ul class="nav nav-tabs" role="tablist">
    
    
        
        
        
        
        <li role="presentation" class="nav-item">
            <button
                type="button"
                class="nav-link active"
                data-bs-toggle="tab"
                id="tab-national"
                data-bs-target="#national"
                aria-controls="national"
                role="tab"
                data-on="click"
data-event-category="Tab change"
data-event-action="Change metadata view"
data-event-label="Change to indicator.national_metadata tab"

            >Nacionalni metapodaci</button>
        </li>
    
        
        
        
        
        <li role="presentation" class="nav-item">
            <button
                type="button"
                class="nav-link "
                data-bs-toggle="tab"
                id="tab-global"
                data-bs-target="#global"
                aria-controls="global"
                role="tab"
                data-on="click"
data-event-category="Tab change"
data-event-action="Change metadata view"
data-event-label="Change to indicator.global_metadata tab"

            >Globalni metapodaci</button>
        </li>
    
        
        
        
        
        <li role="presentation" class="nav-item">
            <button
                type="button"
                class="nav-link "
                data-bs-toggle="tab"
                id="tab-sources"
                data-bs-target="#sources"
                aria-controls="sources"
                role="tab"
                data-on="click"
data-event-category="Tab change"
data-event-action="Change metadata view"
data-event-label="Change to indicator.sources tab"

            >Izvori</button>
        </li>
    
    
    
        <li role="presentation" class="nav-item">
            <button class="nav-link" data-bs-toggle="tab" data-bs-target="#edit" aria-controls="edit" role="tab">Urediti</a>
        </li>
    
</ul>

<div class="tab-content">
    
        
        
        
        
        
        <div role="tabpanel" class="tab-pane active" id="national">
            <article>
                <p>Ova tabela pruža više informacija o indikatoru koji je dostupan iz crnogorske statistike a najbliže odgovara globalnom indikatoru COR. Imajte na umu da i kada je globalni indikator COR u potpunosti dostupan iz crnogorske statistike, ovu tabelu treba konsultovati za informacije o nacionalnoj metodologiji i druge informacije o crnogorskim metapodacima.</p>

                <table class="table">
  
  
  
  
  
  
  
  
      
        
          
      
        
          
      
        
          
      
        
          
      
        
          
      
        
          
      
        
          
      
        
          
  
  
  
  
  
  
  
  
  
  
  
  
  
      
        
          
      
        
          
</table>

            </article>
        </div>
        
        
        
        
        
        <div role="tabpanel" class="tab-pane " id="global">
            <article>
                <p>Ova tabela pruža informacije o metapodacima za COR indikatore koje je definisala Statistička komisija UN-a. <a href="https://unstats.un.org/sdgs/metadata/">Kompletne globalne metapodatke</a> obezbjeđuje Odjeljenje za statistiku UN-a.</p>

                <table class="table">
  
      
        
      
      
      <tr>
        <th scope="row">Cilj </th>
        <td>
          
            <p>Goal 3: Ensure healthy lives and promote well-being for all at all ages</p>

          
        </td>
        </tr>
        
      
  
      
        
      
      
      <tr>
        <th scope="row">Zadatak </th>
        <td>
          
            <p>Target 3.b: Support the research and development of vaccines and medicines for the communicable and non&#x2011;communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all</p>

          
        </td>
        </tr>
        
      
  
      
        
      
      
      <tr>
        <th scope="row">Indikator </th>
        <td>
          
            <p>Indicator 3.b.3: Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis </p>

          
        </td>
        </tr>
        
      
  
      
        
      
      
      <tr>
        <th scope="row">Definicija i koncepti </th>
        <td>
          
            <p><strong>Definition:</strong></p>
<p>Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis.</p>
<p>The indicator is a multidimensional index reported as a proportion (%) of health facilities that have a defined core set of quality-assured medicines that are available and affordable relative to the total number of surveyed health facilities at national level.</p>
<p><strong>Concepts:</strong></p>
<p>Indicator 3.b.3 is defined as the &#x201C;Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis&#x201D;.This indicator is based on the proportion of facilities (pharmacies, hospitals, clinics,primary care centers, public/private, etc.) where core essential medicines from the identified set are available for purchase and their prices are affordable, compared to the total number of facilities surveyed.</p>
<p>There are several core concepts that are used for measuring indicator 3.b.3:</p>
<ol>
  <li>Availability of medicine</li>
  <li>Affordability of medicine</li>
</ol>
<p><strong>&#x2192;</strong>to define affordability, additional concepts are used:</p>
<ul>
  <li>Daily dose treatment of the medicine</li>
  <li>National poverty line</li>
  <li>Wage of the lowest paid unskilled government worker</li>
</ul>
<ol>
  <li>Core set of relevant essential medicines (defined on a global level)</li>
</ol>
<p><strong>&#x2192;</strong>to apply a core set of relevant essential medicines defined on a global level to all countries, an additional concept is used:</p>
<ul>
  <li>global burden of disease</li>
</ul>
<p>1)A medicine is <u>available</u> in a facility when it is found in this facility by the interviewer on the day of data collection. Availability is measured as a binary variable with 1=medicine is available and 0=otherwise.</p>
<p>2) A medicine is <u>affordable </u>when no extra daily wages (EDW) are needed for the lowest paid unskilled government sector worker (LPGW wage) to purchase a monthly dose treatment of this medicine after fulfilling basic needs represented by the national poverty line (NPL). Affordability is measured as a ratio of 1) the sum of the NPL and the price per daily dose of treatment of the medicine (DDD), over 2) the LPGW salary. This measures the number of extra daily wages needed to cover the cost of the medicines in the core set and that can vary between 0 and infinity.</p>
<p><em>2.a) Daily dose of treatment (DDD)</em> is an average maintenance dose per day for a medicine used for its main indication in adults.<sup>2</sup> DDDs allow comparisons of medicine use despite differences in strength, quantity or pack size.</p>
<p><em>2.b) National poverty line (NLP)</em> is the benchmark for estimating poverty indicators that are consistent with the country&apos;s specific economic and social circumstances. NPLs reflect local perceptions of the level and composition of consumption or income needed to be non-poor.</p>
<p>2.c) W<em>age of the lowest paid unskilled government worker (LPGW </em>is a minimum living wage that employees are entitled to receive to ensure overcome of poverty and reduction of inequalities.</p>
<p>In other words, affordability of a medicine identifies how many (if any) extra daily wages are needed for an individual who earns the LPGW wage to be able to purchase a medicine. The computed EDW ratio aims to indicate whether the LPGW wage is enough for the individual who earns the lowest possible income to cover 1) the daily expenditures for food and non-food items used to define (relative or absolute) poverty using national standards (NPL) and 2) the daily needs for a medicine (DDD). This ratio then requires transformation into a binary variable where medicine is affordable when zero extra daily wages are required to purchase it and not affordable otherwise. </p>
<p>3)The <u>core set of relevant essential medicines </u>is a list of 32 tracer essential medicines for acute and chronic, communicable and non-communicable diseases in the primary health care setting.</p>
<p>This basket of medicines has been selected from the 2017 WHO Model List of Essential Medicines and used in primary health care. By definition, essential medicines are those that satisfy the priority health care needs of the population and are selected for inclusion on the Model List based on due consideration of disease prevalence, evidence of efficacy and safety, and consideration of cost and cost-effectiveness.</p>
<p>These medicines are listed in <em>table 1 </em>of <u>Annex 1</u>, where a detailed justification for including each medicine is also provided, as well as online references for the relevant treatment guidelines and sections in the WHO List of Essential Medicines.</p>
<p>This list of medicines is intended as a global reference. However, to address regional and country specificities in terms of medicine needs, the medicines in this basket are weighted according to the regional burden of disease.</p>
<p>3.a) The <em>global burden of disease</em> is an assessment of the health of the world&apos;s population. More specifically, disease burden provides information on the global and regional estimates of premature mortality, disability and loss of health for causes. The summary measure used to give an indication of the burden of disease is the disability adjusted life years (DALYs), which represent a person&#x2019;s loss of the equivalent of one year of full health. This metric incorporates years of life lost due to death and years of life lost through living in states of less than full health (or disability).</p>

          
        </td>
        </tr>
        
      
  
      
        
      
      
      <tr>
        <th scope="row">Izvor podataka </th>
        <td>
          
            <p>SARA, HAI/WHO, EMP MedMon<strong>: </strong>Data is collected by the countries&#x2019; Ministries of Health (MOH), often with the support of the WHO country office. Data is then validated by MoH-based statisticians and shared with WHO by request.</p>

          
        </td>
        </tr>
        
      
  
      
        
      
      
      <tr>
        <th scope="row">Komentar i ograničenja </th>
        <td>
          
            <ol>
  <li>On basket of tracer essential medicines:<ol>
      <li>Although it is possible to regularly monitor all 400+ medicines on the current WHO Model List of Essential Medicines, indicator 3.b.3 requires a specific subset of this list. Over the years, several baskets of medicines have been defined for different purposes and used to conduct data collection and monitor price and availability. This core set of medicines does not replace the other existing baskets, and WHO teams and partners are encouraged and committed to continue ad hoc monitoring through other existing channels. Throughout the process of identifying the core set of medicines, one area of focus has been to balance the selection of the tracer medicines for primary health care with the size of the basket itself. The proposed basket represents a balanced approach to allow that relevant tracer medicines for primary health care are monitored yet ensuring a practical and feasible data collection and analysis. The 32 medicines listed in the basket are meant to be indicative of the access to medicines for primary health care but do not serve as a complete or exhaustive list.</li>
      <li>As mentioned above, each medicine in the basket is weighted according to the regional Disability Adjusted Life Years (DALYs) for relevant disease from the WHO Global health estimates. Regional estimates are less sensitive to country-by-country variability of data quality, they sufficiently illustrate the disease distribution across countries in the region and work well due simplicity and comparability. Hence, regional weights for medicines are used to establish the associated country weights. However, this diminishes the specificity of the basket to the national context.</li>
    </ol>
  </li>
  <li>On the measurement of medicines&#x2019; availability:<ol>
      <li>The proposed approach for measuring the availability of medicines is based on the presence of the medicine on the day that the interviewer visits the facility and does not account for temporary and/or planned stock outs. The 32 medicines identified for the analysis should always be available in the facilities considering that in some (mainly rural) areas, the facility may be very difficult to reach and individuals may not have resources to travel on a daily basis. Moreover, in this proposed methodology the price of the medicine does not take into consideration the so-called indirect costs, which normally include transportation and other costs to reach the facility. Thus, the proposed measure for availability presents some limitations.</li>
    </ol>
  </li>
</ol>
<p>Furthermore, given the data collection occurs at the facility level and does not monitor quantities of any given medicine, an overall analysis of the available medicines compared to the national needs is not possible.</p>
<ol>
  <li>On the measurement of medicines&#x2019; affordability:<ol>
      <li>Affordability of a medicine is often measured as the capacity of the population of a given country to pay for this medicine either ex-ante (usually based on income) or ex-post (usually based on reported expenditures). The latter would mainly require data collected at the individual level and from household surveys. However, information on medicine expenditures in these surveys is not always collected and when collected, is not done so consistently and regularly across the countries. In addition, there is usually a large amount of missing data.</li>
    </ol>
  </li>
</ol>
<p>The ex-ante approach is suggested for the purposes of this indicator as it is measured at the facility level. Ex-ante analysis requires identifying a reference person or group of people for the measurement. The lowest paid unskilled government worker is suggested to serve as the reference for this indicator. In other words, if a medicine is identified as being affordable for the individual who receives the LPGW wage, it will most likely be affordable for all other individuals affiliated with that economic group and higher. This obviously does not account for people employed in the unofficial labour market.</p>
<p>The proposed methodology is an adjusted HAI/WHO methodology. The HAI/WHO approach suggests computing the affordability of medicine prices as the number of daily wages that are required for the lowest paid unskilled government worker (LPGW) to purchase a daily dose of a medicine (DDD). This approach is straightforward and also refers to the capacity of the reference individual to pay for the medicines. However, no threshold was identified to distinguish the maximum number of daily wages that an individual must spend on a medicine in order to still be able to afford it.</p>
<ul>
  <li>
    <ol>
      <li>Information on minimum LPGW wage is available by the International Labour Organization (ILO) for 155 countries. When information is missing or when information has not been updated recently, the alternative measure suggested is to be taken from the World Development Indicators data on &#x201C;minimum wage for a 19-year old worker or an apprentice&#x201D;, which is often used as an alternative in ILO reports.</li>
      <li>The proposed indicator, being measured at the facility level, does not account for potential reimbursement schemes/insurance coverage present at the national level. Information about insurance or other forms of cost-coverage schemes at the national level is not readily available and would require standardization to allow for comparison across countries and income levels of the population. However, as demonstrated by the OECD in its Health at a Glance report in 2015, in 31 high- and middle-income countries the out-of-pocket (OOP) expenditures on pharmaceuticals as a share of all OOP on health varies from 64 to 16%.</li>
    </ol>
  </li>
</ul>
<p>Moreover, there are other SDG indicators, such as 3.8.1 and 3.8.2 that capture coverage of essential health services as well as financial protection from health expenditures net of reimbursement, including expenditures for medicines.</p>
<ol>
  <li>Other dimensions on access to medicines (quality)<ol>
      <li>The quality of the product is another equally important dimension of access to medicines. Currently, there is no systematic and publicly available data collection on quality of a single medicine or in a single country. WHO has, however, contributed to enhanced access to quality health products through different programmes such as regulatory systems strengthening and prequalification.</li>
    </ol>
  </li>
</ol>
<p>A national regulatory authority (NRA) plays a key role in assuring the quality, safety, and efficacy of medical products until they reach the patient/consumer, as well as ensuring the relevance and accuracy of product information. Hence, stable, well-functioning and integrated regulatory systems are an essential component of a health system and contribute to better public health outcomes. NRA maturity and WHO prequalification of medicines can be considered as a proxy for ensuring that medicines in a country are of assured quality. The NRA maturity level is assessed using the WHO National Regulatory Authority Global Benchmarking Tool (WHO NRA GBT). After the evaluations, countries are assigned one of five levels of maturity, with a score of maturity level three representing the minimum acceptable regulatory capacity and maturity level five representing the highest level of functioning.</p>
<p>The importance of transparency and the disclosure of the results of assessments amongst regulators (from ML 3 up) are taken into consideration. However, the information on country-specific NRA maturity level is not currently publicly available and WHO is working to address this limitation through recent discussions on WHO Listed Authorities (WLA).</p>
<ol>
  <li>Other comments:<ol>
      <li>The &#x201C;sustainability&#x201D; dimension in this indicator can be measured only when more than one-time series of computations is available for a specific country so that a trend (tendency of a series of data points to move in a certain direction over time) can be identified.</li>
    </ol>
  </li>
</ol>
<p>The proposed methodology takes advantage of recognized standards and data collection methods, proposing a recombination of dimensions to allow measurement of affordability of a core set of relevant essential medicines for communicable and non-communicable diseases.</p>

          
        </td>
        </tr>
        
      
  
      
        
      
      
      <tr>
        <th scope="row">Disagregacija podataka </th>
        <td>
          
            <p><strong>Data availability:</strong></p>
<p>SARA<strong>: </strong>21 national surveys are currently available from 2010 to 2017 for a total of 13 countries. Two- and three-year trends are available for six countries; the other seven countries only have one data point. 67% of the SDG basket of relevant essential medicines is covered by such surveys. These data will be used to test quality on the availability dimension only.</p>
<p>HAI/WHO:<strong> </strong>Historical data points are available for 55 countries (28%) of all WHO Member States. The highest number of countries captured by the surveys is in the SEARO region (59%) and the smallest is in EURO region (15%). More than 60% of the medicines from the defined SDG indicator basket are captured in the HAI/WHO historical data surveys.</p>
<p><strong>Table 1. </strong>Number of countries captured by the surveys across regions</p>
<table>
  <tbody>
    <tr>
      <td>
        <p><strong><u>WHO Region</u></strong></p>
      </td>
      <td>
        <p><strong><u>2001-2005</u></strong></p>
      </td>
      <td>
        <p><strong><u>2005-2010</u></strong></p>
      </td>
      <td>
        <p><strong><u>2010-2015</u></strong></p>
      </td>
      <td>
        <p><strong><u>Total</u></strong></p>
      </td>
    </tr>
    <tr>
      <td>
        <p><em>African Region</em></p>
      </td>
      <td>
        <p>14</p>
      </td>
      <td>
        <p>5</p>
      </td>
      <td>
        <p>2</p>
      </td>
      <td>
        <p><strong>21</strong></p>
      </td>
    </tr>
    <tr>
      <td>
        <p><em>Region of the Americas</em></p>
      </td>
      <td>
        <p>3</p>
      </td>
      <td>
        <p>7</p>
      </td>
      <td>
        <p>1</p>
      </td>
      <td>
        <p><strong>11</strong></p>
      </td>
    </tr>
    <tr>
      <td>
        <p><em>Eastern Mediterranean Region</em></p>
      </td>
      <td>
        <p>8</p>
      </td>
      <td>
        <p>5</p>
      </td>
      <td>
        <p>3</p>
      </td>
      <td>
        <p><strong>16</strong></p>
      </td>
    </tr>
    <tr>
      <td>
        <p><em>European Region</em></p>
      </td>
      <td>
        <p>5</p>
      </td>
      <td>
        <p>2</p>
      </td>
      <td>
        <p>3</p>
      </td>
      <td>
        <p><strong>10</strong></p>
      </td>
    </tr>
    <tr>
      <td>
        <p><em>South-East Asia Region</em></p>
      </td>
      <td>
        <p>5</p>
      </td>
      <td>
        <p>2</p>
      </td>
      <td>
        <p>1</p>
      </td>
      <td>
        <p><strong>8</strong></p>
      </td>
    </tr>
    <tr>
      <td>
        <p><em>Western Pacific Region</em></p>
      </td>
      <td>
        <p>6</p>
      </td>
      <td>
        <p>2</p>
      </td>
      <td>
        <p>2</p>
      </td>
      <td>
        <p><strong>10</strong></p>
      </td>
    </tr>
    <tr>
      <td>
        <p><strong>Total</strong></p>
      </td>
      <td>
        <p><strong>41</strong></p>
      </td>
      <td>
        <p><strong>23</strong></p>
      </td>
      <td>
        <p><strong>12</strong></p>
      </td>
      <td>
        <p><strong>76</strong></p>
      </td>
    </tr>
  </tbody>
</table>
<p>HAI/WHO surveys were conducted more than once in some of the countries for a total of 76 surveys. </p>
<p>EMP MedMon: In 2016 the design of the EMP MedMon tool for data collection was finalised. Since then, several pilot surveys have been conducted to test the tool. The first pilot survey was conducted across 19 countries using a basket of medicines that captures around 60% of the one currently proposed. The second pilot used a basket adjusted for the purposes of capturing non-communicable diseases only. These pilots have demonstrated that this tool is flexible and can be easily manipulated to include specialized modules of medicines for future data collection.</p>
<p><strong>Time series:</strong></p>
<p>Existing data has been historically collected based on available funding. The majority of existing surveys have been collected thus far using the <strong>HAI/WHO</strong> data collection tool. Most of the existing data points are from 2000 &#x2013; 2005. </p>
<p><strong>Table 2. </strong>Number of surveys and % of medicines from the defined basket </p>
<p>that are captured by HAI/WHO surveys</p>
<table>
  <tbody>
    <tr>
      <td>
        <p> </p>
      </td>
      <td>
        <p><strong><u>2001-2005</u></strong></p>
      </td>
      <td>
        <p><strong><u>2005-2010</u></strong></p>
      </td>
      <td>
        <p><strong><u>2010-2015</u></strong></p>
      </td>
    </tr>
    <tr>
      <td>
        <p><em>Total number of surveys (n)</em></p>
      </td>
      <td>
        <p>41</p>
      </td>
      <td>
        <p>23</p>
      </td>
      <td>
        <p>12</p>
      </td>
    </tr>
    <tr>
      <td>
        <p><em>Medicines captured in the surveys (%)</em></p>
      </td>
      <td>
        <p>49.8%</p>
      </td>
      <td>
        <p>66.3%</p>
      </td>
      <td>
        <p>72.9%</p>
      </td>
    </tr>
  </tbody>
</table>
<p>The distribution of these 76 surveys across WHO regions is represented in<strong> Table 3. </strong></p>
<p><strong>Table 3. </strong>Number of HAI/WHO surveys across regions</p>
<p><img src="data:image/png;base64,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" /></p>
<p>Overall 21 SARA surveys were conducted over the period from 2010 to 2017. 17 surveys were conducted between 2010 and 2015 and 4 surveys after 2015. </p>
<p><strong>Disaggregation:</strong></p>
<p>The proposed indicator will allow for the following disaggregation: </p>
<ol>
  <li>public/private/mission sectors facilities (managing authority)</li>
  <li>geography &#x2013; rural/urban areas</li>
  <li>therapeutic group</li>
  <li>facility type (pharmacy/hospital)</li>
  <li>medicine.</li>
</ol>

          
        </td>
        </tr>
        
      
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
      
        
          
  
  
</table>

            </article>
        </div>
        
        
        
        
        
        <div role="tabpanel" class="tab-pane " id="sources">
            <article>
                
                <!-- Count the non-empty sources (up to 5) -->





            </article>
        </div>
        
    
    
        <div role="tabpanel" class="tab-pane" id="edit">
            <div class="edit-container">
  
  

  
  


  <a class="btn btn-primary" href="data">Urediti podatke</a>
  

  
  <a class="btn btn-primary" href="metadata">Urediti metapodatke</a>
  

  
  <a class="btn btn-primary" href="config">Urediti konfiguraciju</a>
  

</div>

        </div>
    
</div>
  
</div>
  </div>
</div>

  <a href="#top">Povratak na početak</a>
</div>

<footer role="contentinfo">
    <div class="container">
        <div class="row">
            <div class="col">
                <div id="footerLinks">
                    <ul>
                        <li>
                            <a href="https://open-sdg.org">Napravljeno koristeći platformu Open SDG</a>
                        </li>
                        
                        <li>
                            <a href="/site/contact-us">Kontakt</a>
                            
                        </li>
                        <li>
                            <a href="/site/about/cookies-and-privacy/">Kolačići</a>
                            
                        </li>
                        
                        
                        
                        <li>
                            <a href="/site/config">Configuration</a>
                        </li>
                        </ul>
                </div>
            </div>
        </div>
        
    </div>
</footer>

<script src="https://code.jquery.com/jquery-3.4.1.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script>
<script src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.2/dist/js/bootstrap.bundle.min.js" integrity="sha384-MrcW6ZMFYlzcLA8Nl+NtUVF0sA7MsXsP1UyJoMp4YLEuNSfAP+JcXn/tWtIaxVXM" crossorigin="anonymous"></script>
<script src="https://cdn.datatables.net/1.11.5/js/jquery.dataTables.min.js"></script>
<script src="https://cdn.datatables.net/1.11.5/js/dataTables.bootstrap5.min.js"></script>
<script src="//cdn.datatables.net/fixedcolumns/3.2.3/js/dataTables.fixedColumns.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/lodash.js/4.17.20/lodash.min.js" integrity="sha512-90vH1Z83AJY9DmlWa8WkjkV79yfS2n2Oxhsi2dZbIv0nC4E6m5AbH8Nh156kkM7JePmqD6tcZsfad1ueoaovww==" crossorigin="anonymous"></script>
<script src="https://cdn.jsdelivr.net/npm/chart.js@3.7.0/dist/chart.min.js" integrity="sha256-Y26AMvaIfrZ1EQU49pf6H4QzVTrOI8m9wQYKkftBt4s=" crossorigin="anonymous"></script>
<script src="https://cdn.jsdelivr.net/npm/patternomaly@1.3.2/dist/patternomaly.js"></script>

<script src="https://cdn.jsdelivr.net/npm/chartjs-plugin-annotation@1.2.2/dist/chartjs-plugin-annotation.min.js" integrity="sha256-XuHhf6q+GD7fscc96mTm/228GXf1Nn9wOYOE0EgeFzY=" crossorigin="anonymous"></script>


<script src="https://cdnjs.cloudflare.com/ajax/libs/autotrack/2.4.1/autotrack.js"></script>
<script src="https://cdn.jsdelivr.net/npm/html2canvas@1.0.0-rc.3/dist/html2canvas.js"></script>
<script src="https://cdn.jsdelivr.net/npm/file-saver@2.0.2/dist/FileSaver.min.js"></script>







<script>translations['general'] = translations['general'] || {};
    translations['general']['hide'] = 'sakriti';</script>

<script>translations['search'] = translations['search'] || {};
    translations['search']['search'] = 'Pretraga';</script>

<script src='/site/assets/js/sdg.js?v=20220721145210'></script>


    
    
    <script src="/site/assets/js/custom.js?v=20220721145210"></script><script>
    new indicatorInit();
    new accessibilitySwitcher();
</script>


</body>
</html>
